Intestinal microbial overgrowth
ICD-10 K63.82 is a used to indicate a diagnosis of intestinal microbial overgrowth.
Intestinal microbial overgrowth (IMO) is characterized by an abnormal increase in the number of bacteria in the small intestine, which can lead to various gastrointestinal symptoms. Clinically, patients may present with bloating, diarrhea, abdominal pain, and malabsorption of nutrients, which can result in weight loss and nutritional deficiencies. The anatomy involved primarily includes the small intestine, where the overgrowth disrupts normal digestion and absorption processes. Disease progression can vary; if left untreated, it may lead to chronic gastrointestinal issues and complications such as vitamin deficiencies and intestinal damage. Diagnostic considerations include clinical evaluation, patient history, and specific tests such as breath tests or small intestine aspirate cultures to confirm the presence of excessive bacteria. It is crucial to differentiate IMO from other gastrointestinal disorders, such as irritable bowel syndrome (IBS) or celiac disease, to ensure appropriate management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K63.82 covers intestinal microbial overgrowth, which may include conditions such as small intestinal bacterial overgrowth (SIBO) and other related gastrointestinal dysbiosis. Diagnostic criteria typically involve symptoms of malabsorption, bloating, and confirmation through breath tests or cultures.
K63.82 should be used when there is clear evidence of microbial overgrowth in the small intestine, confirmed through diagnostic testing. It is distinct from other codes that may pertain to general gastrointestinal symptoms without specific microbial involvement.
Documentation supporting K63.82 should include a thorough clinical history, symptom description, results from diagnostic tests (e.g., breath tests), and any relevant imaging studies. Clear documentation of the treatment plan and patient response is also essential.
